Agilysys: Needham raises target price to $145 from $135
AGYS•Needham raised its target price for Agilysys to $145 from $135.
Related News
Nasdaq halts trading in Artiva Biotherapeutics pending news
ARTV•
Alpine Income Property Trust Inc: Raymond James cuts target price to $20 from $22
PINE•
Galaxy Digital Q3 net income rebounds on investment gains
GLXY•
Yemen's Houthis say they launched an attack on Saudi Ras Tanura oil refinery
USO•
Pfizer’s Elrexfio outperforms standard regimens in Phase 3 multiple myeloma study
PFE•